Skip to main content

Posts

Featured

From RCT to "real-world" data?

Randomized controlled trials (RCTs) are not always the most useful approach to assess the safety and efficacy of medical devices, says  Professor Bruce Campbell and his colleagues in their comment appeared in a recent issue of the Lancet , because RCTs "may not predict how well a device will work with real-world use." That is why regulators are placing increasing reliance on real-world data , which are collected during routine health care in all patients, rather than selected patients under the controlled conditions of clinical trials. The idea of real-world data sounds very interesting to me, because it provokes the question as to what it takes to be able to claim that a set of data represents the "real-world." It would also be interesting to ask how real-world data are being translated into real-world policies and practices, and how their effects are being experienced by the real-world patients.

Latest Posts